 |
市场调查报告书
商品编码
1166496
麸胺基硫的全球市场:市场规模 - 各类型，各产品，各用途，各地区展望，竞争策略，各市场区隔预测(～2032年)Glutathione Market Size- By Type, By Product, By Application- Regional Outlook, Competitive Strategies and Segment Forecasts to 2032 |
||||||
全球麸胺基硫的市场规模，预计至2032年达到10亿3,000万美元，以8.8％的年复合成长率成长。
麸胺基硫，预计在全球医药品及食品部门的市场占有率扩大。由于COVID-19影响，为缓和症状囤积成药的人变多。免疫力强化的商品需求也扩大，健康辅助食品的需求也高涨。大流行时，由于一般医药品需求增加，麸胺基硫的市场预计增加。
本报告提供全球麸胺基硫市场相关调查，市场动态，市场变数与展望，各类型、产品、用途、地区的市场分析，企业简介等相关资讯。
目录
第1章 简介
- 调查范围
- 市场区隔分析
第2章 调查手法
- 调查资料来源
- 市场规模的估计
- 资料的三角测量
第3章 摘要整理
第4章 市场动态
- 促进因素，阻碍因素，机会，课题的分析
- 促进因素
- 阻碍因素
- 机会
- 课题
- 全球麸胺基硫市场上COVID-19的影响
第5章 市场变数与展望
- SWOT分析
- 优势
- 弱点
- 机会
- 威胁
- PESTEL分析
- 政治形势
- 经济形势
- 社会形势
- 技术形势
- 环境形势
- 法律上的形势
- 波特的五力分析
- 供给企业谈判力
- 买方议价能力
- 替代品的威胁
- 新加入厂商的威胁
- 竞争企业间的敌对关係
- 热图分析
第6章 全球麸胺基硫市场:各类型，2019年～2032年(100万美元)
- L-麸胺基硫
- 乙酰麸胺基硫
第7章 全球麸胺基硫市场:各产品，2019年～2032年(100万美元)
- 氧化型麸胺基硫
- 还原型麸胺基硫
第8章 全球麸胺基硫市场:各用途，2019年～2032年(100万美元)
- 食品、饮料
- 免疫沉淀(IP)
- 个人保养品、化妆品
- 医药品
- 蛋白质纯化
- 研究
- 其他
第9章 全球麸胺基硫市场:各地区，2019年～2032年(100万美元)
- 北美
- 美国
- 加拿大
- 墨西哥
- 欧洲
- 德国
- 英国
- 法国
- 义大利
- 西班牙
- 其他的欧洲
- 亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 其他的亚太地区
- 南美
- 巴西
- 阿根廷
- 其他的南美
- 中东、非洲
- 沙乌地阿拉伯王国
- 阿拉伯联合大公国
- 其他的中东、非洲
第10章 企业简介
- Bio-Rad Laboratories Inc.
- 企业概要
- 财务预测
- 产品概要
- 最近的开发
- Cytiva
- Jarrow Formulas Inc.
- Kaiping Genuine Biochemical Pharmaceutical Co. Ltd.
- Kohjin Life Sciences Co. Ltd.
- Kyowa Hakko Bio Co. Ltd.
- Merck KGaA
- Mitsubishi Corporation Life Sciences Ltd.
- Nissor Pharmaceuticals Ltd.
- Shandong Jincheng Biological Pharmaceutical Co. Ltd.
- Shenzhen GSH Bio-Technology Co. Ltd.
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
Global Glutathione Market Overview:
According to SPER Market Research, the Global Glutathione Market is estimated to reach USD 1.03 billion by 2032 with a CAGR of 8.8%.
A tripeptide substance called glutathione is created from the amino acid glycine, cysteine, and glutamic acid. Important cellular components of the human body are susceptible to damage from reactive oxygen species, including free radicals, peroxides, lipid peroxides, and heavy metals. Glutathione aids in avoiding this damage. An essential antioxidant in the human body, glutathione helps fight free radicals, detoxify substances produced naturally by the body, as well as pharmaceuticals and environmental contaminants. Additionally, glutathione is used to treat impaired immune systems, infertility, and cancer's damaging side effects from radiation and chemotherapy. These advantages of the product ought to increase glutathione's market share in the global pharmaceutical and food sectors.
Impact of COVID-19 on the Global Glutathione Market
The COVID-19 epidemic has altered customers' purchasing behaviour. Panic purchases of food and sanitary supplies have resulted from measures like the countrywide lockdown. A growing number of patients are preferring self-medication over doctor visits in the wake of the COVID-19 issue. As a result, many people have stocked up on over-the-counter medications for symptom alleviation. The demand for goods that aid in strengthening immunity has also grown as a result of greater consumer knowledge of and interest in the significance of preventative health. The need for health supplements has increased as a result. During the pandemic, the market for glutathione is anticipated to rise because to the general increase in demand for medications.
Scope of the Report:
Report Metric Details
- Market size available for years: 2019-2032
- Base year considered: 2021
- Forecast period: 2022-2032
- Segments covered: By Type, By Product, By Application
- Regions covered: North America, Europe, Asia Pacific, Latin America, Middle East and Africa
- Companies Covered: Bio-Rad Laboratories Inc., Cytiva, Jarrow Formulas Inc., Kaiping Genuine Biochemical Pharmaceutical Co. Ltd., Kohjin Life Sciences Co. Ltd., Kyowa Hakko Bio Co. Ltd., Merck KGaA, Mitsubishi Corporation Life Sciences Ltd., Nissor Pharmaceuticals Ltd., Shandong Jincheng Biological Pharmaceutical Co. Ltd., Shenzhen GSH Bio-Technology Co. Ltd., Takara Bio Inc., Thermo Fisher Scientific Inc.
Global Glutathione Market Segmentation:
- By Type: Based on the Type, Global Glutathione Market is segmented as; L-Glutathione, Acetyl-Glutathione.
- By Product: Based on the Product, Global Glutathione Market is segmented as; Oxidized Glutathione, Reduced Glutathione.
- By Application: Based on the Application, Global Glutathione Market is segmented as; Food & Beverages, Immunoprecipitation, Personal Care & Cosmetics, Pharmaceuticals, Protein Purification, Research, Others.
- By Region: Over the projected period, Asia Pacific is expected to develop at the quickest CAGR of any major region, accounting for the greatest revenue share of all other regions. This share is attributable to the expanding government support for domestic manufacturing, which is predicted to increase output levels and lessen reliance on imports in the Asia Pacific area, providing profitable prospects for international manufacturers. Over the projected period, the market is also anticipated to be driven by the expanding pharmaceutical R&D industry. In terms of volume, North America is the largest market, and it is anticipated that it would expand at a significant CAGR over the forecast period. The development of vaccines to treat illnesses like the present Coronavirus pandemic and the increased need for biochemical research applications are two key reasons driving the regional industry. Demand for the product is anticipated to increase in North America due to the growing use of purified proteins and antibodies in medicinal applications.
Table of Contents
1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
2. Research Methodology
- 2.1 Research data source
- 2.1.1 Secondary data
- 2.1.2 Primary data
- 2.1.3 SPER's internal database
- 2.1.4 Premium insight from KOL's
- 2.2 Market size estimation
- 2.2.1 Top-down and Bottom-up approach
- 2.3 Data triangulation
3. Executive Summary
4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1 Drivers
- 4.1.2 Restraints
- 4.1.3 Opportunities
- 4.1.4 Challenges
- 4.2. COVID-19 Impacts of the Global Glutathione Market
5. Market variables and outlook
- 5.1. SWOT analysis
- 5.1.1 Strengths
- 5.1.2 Weaknesses
- 5.1.3 Opportunities
- 5.1.4 Threats
- 5.2. PESTEL analysis
- 5.2.1 Political landscape
- 5.2.2 Economic landscape
- 5.2.3 Social landscape
- 5.2.4 Technological landscape
- 5.2.5 Environmental landscape
- 5.2.6 Legal landscape
- 5.3. PORTER'S five forces analysis
- 5.3.1 Bargaining power of suppliers
- 5.3.2 Bargaining power of Buyers
- 5.3.3 Threat of Substitute
- 5.3.4 Threat of new entrant
- 5.3.5 Competitive rivalry
- 5.4. Heat map analysis
6. Global Glutathione Market, By Type, 2019-2032 (USD Million)
- 6.1. L-Glutathione
- 6.2. Acetyl-Glutathione
7. Global Glutathione Market, By Product, 2019-2032 (USD Million)
- 7.1. Oxidized Glutathione
- 7.2. Reduced Glutathione
8. Global Glutathione Market, By Application, 2019-2032 (USD Million)
- 8.1. Food & Beverages
- 8.2. Immunoprecipitation (IP)
- 8.3. Personal Care & Cosmetics
- 8.4. Pharmaceuticals
- 8.5. Protein Purification
- 8.6. Research
- 8.7. Others
9. Global Glutathione Market, By Region, 2019-2032 (USD Million)
- 9.1 North America
- 9.1.1 United States
- 9.1.2 Canada
- 9.1.3 Mexico
- 9.2 Europe
- 9.2.1 Germany
- 9.2.2 United Kingdom
- 9.2.3 France
- 9.2.4 Italy
- 9.2.5 Spain
- 9.2.6 Rest of Europe
- 9.3 Asia-Pacific
- 9.3.1 China
- 9.3.2 Japan
- 9.3.3 India
- 9.3.4 Australia
- 9.3.5 South Korea
- 9.3.6 Rest of Asia-Pacific
- 9.4 South America
- 9.4.1 Brazil
- 9.4.2 Argentina
- 9.4.3 Rest of South America
- 9.5 Middle East & Africa
- 9.5.1 Kingdom of Saudi Arabia
- 9.5.2 United Arab Emirates
- 9.5.3 Rest of Middle East & Africa
10. Company Profiles
- 10.1 Bio-Rad Laboratories Inc.
- 10.1.1 Company details
- 10.1.2 Financial outlook
- 10.1.3 Product summary
- 10.1.4 Recent developments
- 10.2 Cytiva
- 10.2.1 Company details
- 10.2.2 Financial outlook
- 10.2.3 Product summary
- 10.2.4 Recent developments
- 10.3 Jarrow Formulas Inc.
- 10.3.1 Company details
- 10.3.2 Financial outlook
- 10.3.3 Product summary
- 10.3.4 Recent developments
- 10.4 Kaiping Genuine Biochemical Pharmaceutical Co. Ltd.
- 10.4.1 Company details
- 10.4.2 Financial outlook
- 10.4.3 Product summary
- 10.4.4 Recent developments
- 10.5 Kohjin Life Sciences Co. Ltd.
- 10.5.1 Company details
- 10.5.2 Financial outlook
- 10.5.3 Product summary
- 10.5.4 Recent developments
- 10.6 Kyowa Hakko Bio Co. Ltd.
- 10.6.1 Company details
- 10.6.2 Financial outlook
- 10.6.3 Product summary
- 10.6.4 Recent developments
- 10.7 Merck KGaA
- 10.7.1 Company details
- 10.7.2 Financial outlook
- 10.7.3 Product summary
- 10.7.4 Recent developments
- 10.8 Mitsubishi Corporation Life Sciences Ltd.
- 10.8.1 Company details
- 10.8.2 Financial outlook
- 10.8.3 Product summary
- 10.8.4 Recent developments
- 10.9 Nissor Pharmaceuticals Ltd.
- 10.9.1 Company details
- 10.9.2 Financial outlook
- 10.9.3 Product summary
- 10.9.4 Recent developments
- 10.10 Shandong Jincheng Biological Pharmaceutical Co. Ltd.
- 10.10.1 Company details
- 10.10.2 Financial outlook
- 10.10.3 Product summary
- 10.10.4 Recent developments
- 10.11 Shenzhen GSH Bio-Technology Co. Ltd.
- 10.11.1 Company details
- 10.11.2 Financial outlook
- 10.11.3 Product summary
- 10.11.4 Recent developments
- 10.12 Takara Bio Inc.
- 10.12.1 Company details
- 10.12.2 Financial outlook
- 10.12.3 Product summary
- 10.12.4 Recent developments
- 10.13 Thermo Fisher Scientific Inc.
- 10.13.1 Company details
- 10.13.2 Financial outlook
- 10.13.3 Product summary
- 10.13.4 Recent developments
